Vuong Trieu, CHAIRMAN AND CEO, 10% Owner at Oncotelic Therapeutics, Inc. (OTLC), bought 500,000 shares at $0.02 ($11K) on 2023-06-29, disclosed to the SEC on 2023-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.03 | 75,000 | $2K | 20.9% |
| 2 | $0.02 | 425,000 | $9K | 79.1% |
| Total | $0.02 avg | 500,000 | $11K | 100% |
| Filing → |
| OTLC | BUY | 2026-06-17 | $15K | — | Filing → |
| OTLC | BUY | 2025-07-10 | $2K | — | Filing → |
| OTLC | BUY | 2025-01-31 | $10K | — | Filing → |